Researchers with the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and collaborators have shown that immature natural killer (NK) cells are present in patients with triple-negative ...
Mar 28, 2023
0
40
The breast tumors of Asian, Black and white women have very different cellular, microbial and genomic features that could potentially be used to personalize care or predict disease progression, according to new research by ...
Mar 27, 2023
0
31
Recently published in Clinical Cancer Research, a study led by Alena Gros, Principal Investigator of the Vall d'Hebron Institute of Oncology's Tumor Immunology and Immunotherapy Group, tested more than 500 peptides (amino ...
Mar 21, 2023
0
57
Omomyc is a first in class MYC inhibitor that targets the MYC oncogene which is deregulated in most tumor types. This therapeutic mini-protein was developed in-house by the Vall d'Hebron Institute of Oncology (VHIO) and the ...
Feb 20, 2023
0
2
The distinction between primary tumors and metastases can be made quickly and accurately in brain tumors using radiomics and deep learning algorithms. This is the key message of a study from Karl Landsteiner University of ...
Jan 19, 2023
0
8
Cancer cells have developed multiple mechanisms to thrive. One example, derived from age-old theories of evolution, is positive selection i.e., the propensity of cells with favorable cancer mutations to flourish. However, ...
Jan 18, 2023
0
12
A new research paper titled "Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001" has been published in Oncotarget.
Jan 17, 2023
0
29
CAR T cell therapy, an approach which reprograms patients' own immune cells to attack their blood cancers, may enhance the effectiveness of surgery for solid tumors, according to a preclinical study from researchers in the ...
Jan 11, 2023
0
71
The great hope of cancer immunotherapy is to bolster our own immune cells in specific ways to keep cancer cells from evading our immune system. Although much progress has been made, immunotherapy does not always work well. ...
Dec 19, 2022
0
39
A team at Memorial Sloan Kettering Cancer Center (MSK) has uncovered several mechanisms of immune escape that can help explain why ovarian cancers have been resistant to immunotherapy to date.
Dec 15, 2022
0
52
